Leaflet MODUXIN MR 35mg prolonged-release tablets

Indicated for: angina pectoris

Route of administration: oral

Substance: trimetazidine (antihypertensive)

ATC: C01EB15 (Cardiovascular system | Other cardiac preparations)

Trimetazidine is a medication primarily used for the treatment of angina pectoris (chest pain caused by reduced blood flow to the heart) and other ischemic heart conditions. It works by optimizing the energy metabolism of myocardial cells (heart cells) under conditions of reduced oxygen supply, thereby protecting the heart from the effects of ischemia.

Trimetazidine is used to reduce the frequency and severity of angina episodes, improving exercise tolerance and the quality of life for patients. It may also be used as an adjunct therapy in other conditions involving tissue ischemia.

Side effects are generally rare but may include dizziness, nausea, headaches, or, in very rare cases, tremors or muscle stiffness. It is important to take the medication as prescribed by a doctor and avoid abrupt discontinuation of treatment.

General data about MODUXIN MR 35mg

  • Substance: trimetazidine
  • Date of latest medicines list: 01-06-2026
  • Product code: W59722004
  • Concentration: 35mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 30
  • Product type: Generic medicine
  • Price: 15.76 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: GEDEON RICHTER PLC. - UNGARIA
  • Holder: GEDEON RICHTER ROMANIA S.A. - ROMANIA
  • Number: 14012/2021/01
  • Shelf life: 3 years

Concentrations available for trimetazidine

  • 20mg
  • 20mg/ml
  • 35mg
  • 40mg
  • 80mg

Compensation lists for MODUXIN MR 35mg Gedeon Richter

D - Sublist D with 20% discount from the reference price

Price

Copayment

Patient

15.76 RON

3.15 RON

12.61 RON